Acute and chronic morphine treatments and morphine withdrawal differentially regulate GRK2 and GRK5 gene expression in rat brain
- PMID: 12384166
- DOI: 10.1016/s0028-3908(02)00147-8
Acute and chronic morphine treatments and morphine withdrawal differentially regulate GRK2 and GRK5 gene expression in rat brain
Abstract
Opioid agonist stimulates activation of G protein-coupled receptor kinase (GRK) and causes desensitization of opioid signaling, which plays an important role in opioid tolerance. The current study investigated the potential regulatory effects of acute and chronic morphine administration and withdrawal on GRK2 and GRK5 gene expression in rat brain. Our results showed that the initial morphine treatment (10 mg/kg) significantly increased GRK mRNA levels in cerebral cortex, hippocampus, and lateral thalamic nuclei. A significant decrease in GRK5 mRNA levels was observed in periaqueductal gray. In strong contrast, repeated administration of morphine for 9 days failed to cause any significant increase in GRK5 mRNA in any of these brain regions. Chronic morphine treatment resulted in 30-70% down-regulation of GRK2 expression in cerebral cortex, hippocampus, thalamus, and locus coeruleus, opposite to what observed with the single morphine administration. Moreover, spontaneous and naloxone-precipitated morphine withdrawal resulted in aberrant increases in GRK2 and GRK5 mRNA levels in these brain regions. Taken together, our study suggests that opioid not only induces rapid negative feedback regulation on opioid signals through activation of GRK but also exerts its impact, via controlling levels of GRK gene expression, on the regulatory machinery itself over a longer period of time in brain.
Similar articles
-
[Regulation of G protein-coupled receptor kinase 5 mRNA and protein level in rat brain by addictive drugs].Sheng Li Xue Bao. 2004 Oct 25;56(5):559-65. Sheng Li Xue Bao. 2004. PMID: 15497034 Chinese.
-
Differential regulation of beta-arrestin 1 and beta-arrestin 2 gene expression in rat brain by morphine.Neuroscience. 2003;117(2):383-9. doi: 10.1016/s0306-4522(02)00930-2. Neuroscience. 2003. PMID: 12614678
-
G protein-coupled receptor kinase 2 mediates mu-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus.J Neurochem. 2001 Apr;77(2):435-44. doi: 10.1046/j.1471-4159.2001.00267.x. J Neurochem. 2001. PMID: 11299306
-
Morphine-induced changes of gene expression in the brain.Addict Biol. 2005 Mar;10(1):81-9. doi: 10.1080/13556210412331308994. Addict Biol. 2005. PMID: 15849022 Review.
-
Targeting GRK2 and GRK5 for treating chronic degenerative diseases: Advances and future perspectives.Eur J Med Chem. 2022 Dec 5;243:114668. doi: 10.1016/j.ejmech.2022.114668. Epub 2022 Aug 13. Eur J Med Chem. 2022. PMID: 36055000 Review.
Cited by
-
CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.J Neuroimmunol. 2010 Jul 27;224(1-2):108-13. doi: 10.1016/j.jneuroim.2010.05.002. J Neuroimmunol. 2010. PMID: 20554030 Free PMC article.
-
GRK5 Deficiency Causes Mild Cognitive Impairment due to Alzheimer's Disease.J Alzheimers Dis. 2022;85(4):1399-1410. doi: 10.3233/JAD-215379. J Alzheimers Dis. 2022. PMID: 34958040 Free PMC article. Review.
-
Sensitization to the conditioned rewarding effects of morphine modulates gene expression in rat hippocampus.Neuropharmacology. 2007 Feb;52(2):430-5. doi: 10.1016/j.neuropharm.2006.08.012. Epub 2006 Oct 2. Neuropharmacology. 2007. PMID: 17014870 Free PMC article.
-
A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the μ-Opioid Receptor.Mol Pharmacol. 2020 Jun;97(6):392-401. doi: 10.1124/mol.119.118661. Epub 2020 Mar 31. Mol Pharmacol. 2020. PMID: 32234810 Free PMC article.
-
Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons.Br J Pharmacol. 2012 Mar;165(6):1704-1716. doi: 10.1111/j.1476-5381.2011.01482.x. Br J Pharmacol. 2012. PMID: 21564086 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases